33 results
PRER14A
BXRXQ
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
to the closing of the Acquisition and approved by the Nominating and Corporate Governance
Committee of the Company’s Board of Directors shall be appointed … of the pharmaceutical industry,
Notice of Special Meeting of Shareholders and Proxy Statement |
her corporate governance experience as a board member
DEFA14A
BXRXQ
Baudax Bio, Inc.
5 Jul 23
Additional proxy soliciting materials
5:28pm
its first date of listing on Nasdaq, has been, in compliance in all material respects with the applicable current listing and governance rules … set forth on Exhibit D and approved by the Nominating and Corporate Governance Committee of the Parent Board (each, an “Additional Company Board
8-K
EX-2.1
BXRXQ
Baudax Bio, Inc.
5 Jul 23
Entry into a Material Definitive Agreement
5:26pm
its first date of listing on Nasdaq, has been, in compliance in all material respects with the applicable current listing and governance rules … set forth on Exhibit D and approved by the Nominating and Corporate Governance Committee of the Parent Board (each, an “Additional Company Board
424B3
65odjxc8zzeimn7 a48
28 Apr 23
Prospectus supplement
4:02pm
8-K
EX-10.2
j5w1wymfk26hri4lf
31 Mar 23
Entry into a Material Definitive Agreement
4:50pm
DEFA14A
2ywt44zemrnq0p9kq6
1 Jul 21
Additional proxy soliciting materials
7:15am
DEFA14A
0wnq8o2
30 Jun 21
Additional proxy soliciting materials
7:15am
DEFA14A
8qiwob3sz2j
13 May 21
Additional proxy soliciting materials
7:30am
DEFA14A
qkq3d
12 May 21
Additional proxy soliciting materials
9:11am
PRE 14A
aim7ky
1 Mar 21
Preliminary proxy
5:29pm
8-K
EX-10.1
52kij cdq
22 Jan 21
Entry into a Material Definitive Agreement
5:26pm